EP Patent

EP4374861A3 — A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue

Assigned to MedinCell SA · Expires 2024-08-07 · 2y expired

What this patent protects

A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a di…

USPTO Abstract

A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP4374861A3
Jurisdiction
EP
Classification
—
Expires
2024-08-07
Drug substance claim
No
Drug product claim
No
Assignee
MedinCell SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.